PRKN and diabetes mellitus: Consequently, platelet Parkin may play a regulatory role in mitophagy and platelet activation in diabetes, presenting itself as a promising therapeutic target.429 Metformin is the first-line drug for the treatment of type 2 diabetes and the only drug that has been proven to reduce cardiovascular complications in diabetes patients.